Your session is about to expire
← Back to Search
Q-Urol for Prostatitis (Q-Urol Trial)
Q-Urol Trial Summary
This trial will study whether Q-Urol can relieve prostatitis symptoms in men with localized prostate cancer who have undergone brachytherapy.
Q-Urol Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowQ-Urol Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Q-Urol Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of irritable bowel syndrome, chronic fatigue syndrome, fibromyalgia, or bladder pain syndrome (IC/BPS).You have had or currently have another type of cancer that could affect the evaluation of the new treatment.You have a history of low blood pressure, falling, or fainting.You have a history of low blood sugar (hypoglycemia).You are currently using alcohol or drugs in a harmful or dangerous way.You have had a very severe allergic reaction to the study drug or any of its ingredients in the past.You are allergic to pineapple or anything that has pineapple in it.Your urinary symptoms, as measured by the AUA symptom score, are more severe than a score of 15.
- Group 1: Arm 2: Placebo
- Group 2: Arm 1: Q-Urol
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are being observed in this experiment?
"That is correct, the online information states that this clinical trial has open enrollment and is looking for 140 patients from 2 different locations."
Can people still apply to participate in this experiment?
"The information available on clinicaltrials.gov verifies that this trial is looking for subjects as we speak. The original posting was on 6/13/2022, and there have been no updates since then. They are hoping to enroll 140 patients at 2 different hospitals."
Is Arm 1: Q-Urol likely to cause any harm to patients?
"Arm 1: Q-Urol was given a safety rating of 2. While there is some data supporting safety, none of it speaks to the efficacy of this medication."
Share this study with friends
Copy Link
Messenger